Tissue Engineering of Human Septal Cartilage Using a Rotary Bioreactor
DOI:
https://doi.org/10.12970/2311-1755.2014.02.01.3Keywords:
Cartilage tissue engineering, human nasal septal tissue, bioreactor, rotary vessel, cartilage constructs, cartilage reconstruction.Abstract
Tissue engineering of human septal neocartilage offers the potential to produce large quantities of autologous material for use in the repair of cartilaginous craniofacial defects. Culture of septal neocartilage constructs in a rotary cell culture system bioreactor may improve the biochemical and biomechanical properties of engineered tissue. The objective of this study was to characterize the morphological, compositional and mechanical properties of engineered human septal cartilage constructs when cultured in three different environments. Human septal cartilage constructs were cultured in transwell plates for 6 weeks and subsequently cultured for an additional 4 weeks in transwell plates, free-floating in a sterile media bottle, or in a rotary cell culture system bioreactor. The histologic, biochemical, and biomechanical properties of the constructs were examined. All constructs maintained their radial dimensions throughout the culture period. Qualitatively, the constructs cultured in the rotary cell culture system bioreactor were firmer and more resilient compared with the constructs cultured under free-floating static and transwell plate conditions. Culture of human septal neocartilage constructs in a rotary cell culture system bioreactor augmented cell proliferation and extracellular matrix production when compared with constructs cultured in transwell plates and free-floating static conditions. Additionally, rotary cell culture system bioreactor culture enhanced total and type II collagen production. The rotary cell culture system bioreactor constructs possessed improved biomechanical properties compared with the other conditions and this is reflected in their superior resistance to manipulation. These findings suggest that culture in a rotary cell culture bioreactor can modulate the composition and mechanical function of engineered scaffold-free human septal cartilage constructs to produce constructs better suited for reconstructive surgery.
References
Tardy ME Jr., Denneny J 3rd, Fritsch MH. The versatile cartilage autograft in reconstruction of the nose and face. Laryngoscope 1985; 95: 523-33. http://dx.doi.org/10.1288/00005537-198505000-00003
Komender J, Marczynski W, Tylman D, Malczewska H, Komender A, Sladowski D. Preserved tissue allografts in reconstructive surgery. Cell Tissue Bank 2001; 2: 103-12. http://dx.doi.org/10.1023/A:1014333022132
Collawn SS, Fix RJ, Moore JR, Vasconez LO. Nasal cartilage grafts: more than a decade of experience. Plast Reconstr Surg 1997; 100: 1547-52. http://dx.doi.org/10.1097/00006534-199711000-00027
Romo T 3rd, McLaughlin LA, Levine JM, Sclafani AP. Nasal implants: autogenous, semisynthetic, and synthetic. Facial Plast Surg Clin North Am 2002; 10: 155-66. http://dx.doi.org/10.1016/S1064-7406(02)00006-8
von der Mark K, Gauss V, von der Mark H, Muller P. Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature 1977; 267: 531-2. http://dx.doi.org/10.1038/267531a0
Homicz MR, Schumacher BL, Sah RL, Watson D. Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg 2002; 127: 398-408. http://dx.doi.org/10.1067/mhn.2002.129730
Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982; 30: 215-24. http://dx.doi.org/10.1016/0092-8674(82)90027-7
Homicz MR, Chia SH, Schumacher BL, et al. Human septal chondrocyte redifferentiation in alginate, polyglycolic acid scaffold, and monolayer culture. Laryngoscope 2003; 113: 25-32. http://dx.doi.org/10.1097/00005537-200301000-00005
Chia SH, Homicz MR, Schumacher BL, et al. Characterization of human nasal septal chondrocytes cultured in alginate. Characterization of human nasal septal chondrocytes cultured in alginate. J Am Coll Surg 2005; 200: 691-704. http://dx.doi.org/10.1016/j.jamcollsurg.2005.01.006
Alexander TH, Sage AB, Schumacher BL, Sah RL, Watson D. Human serum for tissue engineering of human nasal septal cartilage. Otolaryngol Head Neck Surg 2006; 135: 397-403. http://dx.doi.org/10.1016/j.otohns.2006.05.029
Alexander TH, Sage AB, Chen AC, et al. IGF-1 and GDF-5- promote the formation of tissue-engineered human nasal septal cartilage. Tissue Eng Part C Methods 2010; 16: 1213-21. http://dx.doi.org/10.1089/ten.tec.2009.0396
Homicz MR, McGowan KB, Lottman LM, Beh G, Sah RL, Watson D. A compositional analysis of human nasal septal cartilage. Arch Facial Plast Surg 2003; 5: 53-8. http://dx.doi.org/10.1001/archfaci.5.1.53
Neuman MK, Briggs KK, Masuda K, Sah RL, Watson D. A compositional analysis of cadaveric human nasal septal cartilage. Laryngosope 2013; 123: 2120-4. http://dx.doi.org/10.1002/lary.23727
Richmon JD, Sage A, Wong VW, Chen AC, Sah RL, Watson D. Compressive biomechanical properties of human nasal septal cartilage. Am J Rhinol 2006; 20: 496-501. http://dx.doi.org/10.2500/ajr.2006.20.2932
Richmon JD, Sage AB, Wong VW, et al. Tensile biomechanical properties of human nasal septal cartilage. Am J Rhinol 2005; 19: 617-22.
Chang AA, Reuther MS, Briggs KK, et al. In vivo implantation of tissue-engineered human nasal septal neocartilage constructs: a pilot study. Otolaryngol Head Neck Surg 2012; 146: 46-52. http://dx.doi.org/10.1177/0194599811425141
Vinatier C, Mrugala D, Jorgensen C, Guicheux J, Noel D. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 2009; 27: 307-14. http://dx.doi.org/10.1016/j.tibtech.2009.02.005
Sutherland SM, Sordat B, Bamat J, Gabbert H, Bourrat B, Mueller-Klieser W. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res 1986; 46: 5320-9.
Freed LE, Langer R, Martin I, Pellis NR, Vunjak-Nokakovic G. Tissue engineering of cartilage in space. Proc Natl Acad Sci USA 1997; 94: 13885-90. http://dx.doi.org/10.1073/pnas.94.25.13885
Lappa M. Organic tissues in rotating bioreactors: fluid-mechanical aspects, dynamic growth models, and morphological evolution. Biotechnol Bioeng 2003; 84: 518-32. http://dx.doi.org/10.1002/bit.10821
Martin I, Obradovic B, Treppo S, et al. Modulation of the mechanical properties of tissue engineered cartilage. Biorheology 2000; 37: 141-7.
McGowan KB, Kurtis MS, Lottman L, Watson D, Sah RL. Biochemical quantification of DNA in human articular and septal cartilage using PicoGreen and Hoechst 33258. Osteoarthritis Cartilage 2002; 10: 580-7. http://dx.doi.org/10.1053/joca.2002.0794
Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883: 173-7. http://dx.doi.org/10.1016/0304-4165(86)90306-5
Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-7. http://dx.doi.org/10.1016/0003-9861(61)90291-0
Jackson DS, Cleary EG. The determination of collagen and elastin. Methods Biochem Anal 1967; 15: 25-76. http://dx.doi.org/10.1002/9780470110331.ch2
Scott JE, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 1965; 5: 221-33. http://dx.doi.org/10.1007/BF00306130
Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol 2004; 22: 80-6. http://dx.doi.org/10.1016/j.tibtech.2003.12.001
Li WJ, Jiang YJ, Tuan RS. Cell-Nanofiber-based cartilage tissue engineering using improved cell seeding, growth factor, and bioreactor technologies. Tissue Eng Part A 2008; 14: 639-48. http://dx.doi.org/10.1089/tea.2007.0136
Sheehy, EJ, Buckley CT, Kelly DJ. Chondrocytes and bone marrow-derived mesenchymal stem cells undergoing chondrogenesis in agarose hydrogels of solid and channelled architectures respond differentially to dynamic culture conditions. J Tissue Eng Regen Med 2011; 5: 747-58. http://dx.doi.org/10.1002/term.385
Vunjak-Novakovic G, Martin I, Obradovic B, et al. Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res 1999; 17: 130-8. http://dx.doi.org/10.1002/jor.1100170119
Pound JC, Green DW, Chaudhuri JB, Mann S, Roach HI, Oreffo RO. Strategies to promote chondrogenesis and osteogenesis from human bone marrow cells and articular chondrocytes encapsulated in polysaccharide templates. Tissue Eng 2006; 12: 2789-99. http://dx.doi.org/10.1089/ten.2006.12.2789
Marlovits S, Tichy B, Truppe M, Gruber D, Vécsei V. Chondrogenesis of aged human articular cartilage in a scaffold-free bioreactor. Tissue Eng 2003; 9: 1215-26. http://dx.doi.org/10.1089/10763270360728125
Ohyabu Y, Kida N, Kojima H, Taguchi T, Tanaka J, Uemura T. Cartilaginous tissue formation from bone marrow cells using rotating wall vessel (RWV) bioreactor. Biotechnol Bioeng 2006; 95: 1003-8. http://dx.doi.org/10.1002/bit.20892
Sakai S, Mishima H, Ishii T, et al. Rotating three-dimensional dynamic culture of adult human bone marrow-derived cells for tissue engineering of hyaline cartilage. J Orthop Res 2009; 27: 517-21. http://dx.doi.org/10.1002/jor.20566
Gorti GK, Lo J, Falsafi S, et al. Cartilage tissue engineering using cyrogenic chondrocytes. Arch Otolaryngol Head Neck Surg 2003; 129: 889-93. http://dx.doi.org/10.1001/archotol.129.8.889
Reuther MS, Wong VW, Briggs KK, et al. Culture of human septal chondrocytes in a rotary bioreactor. Orolaryngol Head Neck Surg 2012; 147: 661-7. http://dx.doi.org/10.1177/0194599812448049